baber/WOPTO huggingface dataset:
Patent ES-8503341-A1 (ES)
Title: 2-Heterocyclyl oxy-alkyl-4(1H)-pyrimidone derivs.
IPC: C07D239/36
Filed: 1983-09-22
Abstract: 2-Heterocyclyloxyalkyl- 4(1H)-pyrimidone derivs. of formula (I) and their salts are new. (R1 is H, 1-10C alkyl, 2-5C alkenyl, 2-5C alkynyl, Ph, cycloalkylmethyl, opt. substd. aralkyl or A-NR3R4 A is 1-5C alkylene R3 and R4 are 1-5C alkyl or NR3R4 is piperidino or pyrrolidino R2 is H, 1-5C alkyl or CF3 Y is 5-dimethylamino-2-furyl, m-(N-piperidinomethyl)phenyl or a heterocyclic gp. of formula (II) R is H or 1-5C alkyl B is O or S m is 0-3 and n is 1-3). Intermediates of formulae (II) and (III) are new (sic.). (R5 is 1-5C alkyl). (I) are inhibitors of gastric acid secretion, anti-inflammatory agents and agents for treating cardiovascular and stomach diseases. (I R1 is 4-9C alkyl) have a cytoprotective action as well as histamine H2-receptor blocking activity. Dose is 0.1-0.8 g daily in 1-4 doses. Specifically claimed are 8 cpds. (I), including 5-(p-t-butyl-benzyl)-2- 2-(((2- ((diaminomethylene) amino)-4-thiazolyl) methyl)thio)ethyl)-6-methyl-4(1H)-pyrimidone and the corresp. 5-n-butyl and 5-n-pentyl cpds.
Patent ES-8502408-A1 (ES)
Title: Electrolytic water sterilization system.
IPC: C02F1/46
Filed: 1983-11-29
Abstract: An electrolytic water sterilization system comprises a rate detecting cell, an oxidation cell and a silvering cell through which the water flows. The rate detecting cell is fitted with two electrodes and is partly filled with non-conducting particles whose density is greater than water. The upwards flow of water expands the bed of particles providing greater free area between the electrodes. The electrical resistance between the electrodes is reduced accordingly. The current to the electrodes of the oxidation cell and the silvering cell is controlled by the detected flow rate. Preferably, the rate detecting cell, the oxidation cell and the silvering cell with their corresponding electrodes are combined in one single cell.
Patent ES-8604146-A1 (ES)
Title: Piperidine derivatives, process for their preparation and pharmaceutical compositions containing them.
IPC: C07D211/14
Filed: 1983-12-27
Abstract: Piperidines of formula (I) and their acid-addn. and quat. ammonium salts are new. R1=halogen, trihalomethyl, 1-4C alkyl, or 1-4C alkoxy R2=1-4C alkyl (sic). - Cpds. (I) in which R2=H are also described and 4 are specifically claimed.
Patent ES-8504889-A1 (ES)
Title: Method of re-using asphalt covering and asphalt covering mass produced according to the method.
IPC: C08L95/00
Filed: 1984-01-05
Abstract: A method of re-using cutted masses or crushed masses of old asphalt coverings indoors and outdoors by reactivating the cutted or crushed asphalt mass, whereby the old asphalt covering is cutted or broken up to a grain size of up to 100 mm or preferably 20-40 mm and in cold condition or heated up to 50 DEG C is mixed with 1-4 or preferably 2-3 % by weight of a bitumenous foam containing 0.1-10 or preferably 1-3 by weight of water and having a temperature of 110-250 DEG C or preferably 140-180 DEG C. Up to 30 % by weight as a maximum of the cutted mass or the crushed mass can be substituted by a stone material having a grain size of 10-30 mm for improving the grain structure of the asphalt mixture, and a slight amount of an adhesion agent and/or a plastic or cautchouc agent may be added. The binder of bitmuenous foam may contain bitumen, tar, and asphalt solution, a combination of bitumen and tar and/or plastic or a rubber modified binder or any equivalen other rock oil product. The invention also relates to an asphalt covering mass produced according to the above method.
Patent ES-8501781-A1 (ES)
Title: Process for the preparation of urea condensation products, and their use.
IPC: C08G71/00
Filed: 1984-03-30
Abstract: The present invention relates to a process for the preparation of urea condensates and to their use. To prepare these urea condensates, a primary di and/or polyamine is reacted with urea, a secondary monoamine and if appropriate a polyalcohol at elevated temperatures in the presence or absence of catalysts, and the ammonia formed is separated off. These urea condensates are suitable as binder components in thermosetting surface coatings.
Patent ES-8603552-A1 (ES)
Title: An effervescent composition suitable for effervescent tablets
IPC: C09K3/00
Filed: 1984-09-28
Abstract: An effervescent composition, more particularly for effervescent tablets, contains at least one solid crystalline organic acid and at least one carbonate which liberates CO2 on reaction with the organic acid, the acid crystals having a coating which contains calcium carbonate and which adheres to their surface by means of a bonding layer formed by surface-reaction of the calcium carbonate containing coating material with a surface layer of each acid crystal. The effervescent tablets may also contain minerals and/or vitamins or acetylsalicylic acid, the latter being present, optionally, with paracetamol in a two-layer structure.
Patent ES-8507569-A1 (ES)
Title: Chemical process for preparing antibiotic L 17392 (Deglucoteicoplanin) and its salts.
IPC: C07D245/00
Filed: 1984-12-14
Abstract: The present invention is directed to a chemical process for preparing antibiotic L 17392 (deglucoteicoplanin) and its salts with bases and acids by submitting a teicoplanin compound or a teicoplanin-like compound to controlled strong acidic hydrolysis conditions.
Patent ES-8605084-A1 (ES)
Title: Improvements relating to the lining of passageways and pipelines.
IPC: F16L58/10
Filed: 1985-01-04
Abstract: Pipeline or passageway is lined by applying a lining of resin absorbent material which is impregnated with a curable resin containing a radiation initiating catalyst, and effecting or initiating the cure of the resin with the lining in position by light radiation, the resin and fibrous material being selected so that the resin and fibres have similar refractive indexes, and the light being selected to give good penetration of the light radiation into the resin and the felt. - Lining has a membrane on its inner surface which is transparent to the curing light radiation. The felt is of bright acrylic fibres, and the resin is pref. ''Palatal 55-54'' RTM BASF. The lining is held in position by clean water and the radiation lamps are immersed in the water.
Patent ES-8607096-A1 (ES)
Title: Extrusion die head assembly for plastic pelletizers.
IPC: B29C48/30
Filed: 1985-01-08
Abstract: An extrusion die head assembly for thermoplastic material pelletizers is disclosed having a body member and a mating, removable and selectively substitutable relatively small mass insert member in communication with the body member, the insert member having a selected plurality of metering capillary and communicating extrusion die passages positioned therein, the dimensions, number and positioning of the metering capillary passages being selected as required by the physical and rheological properties of the thermoplastic material being processed through said assembly.
Patent ES-8601391-A1 (ES)
Title: Diesel engine piston combustion chamber
IPC: F02B23/02
Filed: 1985-01-16
Abstract: An arrangement or structure for main combustion chambers for a diesel engine of the direct-injection type, which main combustion chamber has a peripheral wall which includes a plurality of impact (shock) or collision walls and guide walls arranged alternately with respect to one another in the circumferential direction of the piston, which is characterized in that each guide wall includes a countercurrentwise portion and a currentwise portion with a limit zone located between them with respect to the direction of the vortex where the radial distance from the centre of the chamber to the limit zone is shorter than the radial distance from the centre of the chamber to the other portions, and in that each countercurrentwise portion will have a radius of curvature and a circumferential length which are greater than the currentwise portion so that the inner periphery of said chamber adopts a configuration similar to a toothed wheel.
Patent ES-8606967-A1 (ES)
Title: Time-multiplex digital cellular radio system.
IPC: H04B1/30
Filed: 1985-02-01
Abstract: 1. Digital cellular radio system with fixed transmitting-receiving stations and with mobile transmitting-receiving stations which can exchange communications with the fixed stations by radio in time division multiplex with multiple access, wherein several fixed stations are controlled from one master station, of which in turn several are connected by relay station with a telephone dialling network, characterised thereby, that the transmitting-receiving stations are equipped for the radio traffic by a residual side band method with suppressed carrier of the frequency f0 in conjunction with a PAK modulation, that the receiving stations display an analog quadrature input part, in which the reception band is mixed with an auxiliary frequency fH = f0 - B6 /2 to an intermediate frequency of zero and selected by low-pass filters (TP), wherein the 6dB-bandwidth of the receiver is designated by B6 , that analog-to-digital converters (A/D) for both quadrature channels follow the analog input part and that the digitalised signals experience a one-sided frequency shift through fH - f0 through complex multiplication (M) with a rotary vector of the magnitude exp[-2 pi j(fH -f0 )t].
Patent ES-8602460-A1 (ES)
Title: Method for casting a liquid metal.
IPC: B22D27/00
Filed: 1985-02-22
Abstract: A protective gas shield is formed around steel, to prevent oxidn. from the moment of pouring to the moment of solidification, by use of liq. and/or solid and/or gaseous carbon dioxide. - In ingot casting, the ingot mould is purged with carbon dioxide and the molten steel is teemed into the mould under the protection of a carbon dioxide shield such that the mould is filled with a carbon dioxide cover which covers the steel until it solidifies. In this embodiment, the carbon dioxide shield may be (partially) replaced by an argon shield. - In continuous casting, the molten stream is protected by carbon dioxide from the moment of formation until the moment it solidifies.
Patent ES-8603184-A1 (ES)
Title: B-Carboline-3-carboxylic acid derivatives, method of preparing the same and their use.
IPC: C07D209/18
Filed: 1985-05-14
Abstract: New beta -carboline-3-carboxylic acid esters having the general formula I: < CHEM > wherein R<4>, R<5> and R<6> have specified meanings. The new compounds which exhibit surprising psychotropic properties are prepared by an analogy method.
Patent ES-8606899-A1 (ES)
Title: Human interleukin prodn.
IPC: C12N15/00
Filed: 1985-07-19
Abstract: Human Interleukin 2 for clinical use as reinforcer of both cellular and humoral immune response in the normal state or in states of immuno-deficiency and auto-immune disease, is made by (a) aerobic cultivation in YEME medium at 28 deg.C for 5-7 days at 200 rpm., in presence of 50 g/ml. (sic) thiostreptone anti-biotic, of streptomyces cells transformed with a plasmid contg. an insert which codifies for human Interleukin 2, cloned in plasmid vector of S. Livdans contg. signals for transcription and translation of E. coli, thanks to a synthetic promoter and a union site with the synthetic ribosome; and (b) isolating the Interleukin 2 produced in the medium by electrophoresis in polyacrylamide gel.
Patent ES-8604585-A1 (ES)
Title: 1,6-Naphthyridin derivatives useful as cardiotonics and preparation thereof.
IPC: C07D471/04
Filed: 1985-08-16
Abstract: 4-R min -5-Q-1,6-naphthyridin-2(1H)-ones (1), where R min is hydrogen or methyl and Q is hydroxymethyl, 1-hydroxyethyl alkanoyloxymethyl or 1-alkanoyloxyethyl, are produced by first reacting 4-R min -5-acetyl (or n-propanoyl)-6[2-(dilower-alkylamino]-2(1H)-pyridinone (III) with hydroxylamine or salt thereof to produce 4-R min -5-Q min -1,6-naphthyridin-2(1H)-one-6-oxide (II), where R min is defined as above and Q min is methyl or ethyl next reacting II with an alkanoic anhydride to produce I where Q is alkanoyloxymethyl or 1-alkanoyloxyethyl and, then hydrolyzing said alkanoyloxymethyl or -ethyl compound to produce I where Q is hydroxymethyl or 1-hydroxyethyl. Also shown is the cardiotonic use of II and I where Q is hydroxymethyl, 1-hydroxyethyl or alkanoyloxymethyl.
Patent ES-8606452-A1 (ES)
Title: Anti-fouling paint.
IPC: C09D133/04
Filed: 1985-10-23
Abstract: A self-polishing anti-fouling paint comprises a biocide for marine organisms and a binder which is a linear synthetic film-forming polymer carrying a plurality of free carboxylic acid groups or carboxylic anhydride groups and having an equivalent weight of from 240 to 750. The binder is preferably an additional copolymer of one or more olefinically unsaturated acids or anhydrides.
Patent ES-8704980-A1 (ES)
Title: Improvements in the polymerization of norbornene-type cycloolefins.
IPC: C08F4/60
Filed: 1985-11-16
Abstract: A method of preparing a thermoset, cross-linked polymer of a norbornene-type monomer - particularly dicyclopentadiene - is disclosed wherein a reactant stream containing a metathesis catalyst is combined with a second reactant stream containing an activator, and the combined streams are immediately injected into a mold wherein polymerization and cross-linking take place to form a shaped object. The method is characterized by a two part activator comprised of dialkylaluminum chloride or a trialkyl aluminum compound as one part and a dialkylaluminum iodide as the second part. The two part activator delays the occurrence of cross-linking, thereby allowing a somewhat longer time for transfer of the combined streams to the mold and distribution thereof throughout the mold. It also leads to more complete polymerization.
Patent ES-8802582-A1 (ES)
Title: Stabilized plasminogen activator precursor and method of producing the same.
IPC: A61K47/34
Filed: 1986-01-28
Abstract: A plasminogen activator precursor obtainable from a serum-free culture fluid of human kidney cells is stabilized by adding to its solution poly-C1-C5-alkylene glycols, polyethylene-polyoxypropylene copolymers, mandelic acid salts, triethanolamine, acid addition salts of acetylglycillysine methyl ester, guanidine salts, thiocyanic acid salts, alkali metal iodides or serine.
Patent ES-8705028-A1 (ES)
Title: Controlled generation hypochlorite compositions and method.
IPC: C11D3/395
Filed: 1986-02-28
Abstract: A dry bleaching composition, particularly useful for low temperature applications, is provided in which generation of hypochlorite by reaction between a peroxygen bleaching agent and a chloride salt is promoted by an aromatic diol or oxidized aromatic diol activator. Preferred activators are in ester form and provide hypochlorite generation at levels of less than about 20 ppm for at least about the first two minutes following dissolution of the compositions in aqueous solution, but rising to effective bleaching levels within a reasonable time thereafter. The initially low hypochlorite level assists in the functioning of laundry additives, such as fabric brighteners.
Patent ES-8704212-A1 (ES)
Title: Crystallisation of fructose.
IPC: C13K11/00
Filed: 1986-03-13
Abstract: A continuous process for the crystallization of fructose from an aqueous fructose syrup containing at least 90% by weight fructose on a dry solids basis, in which the syrup at a total solids content of at least 95% by weight is rapidly and thoroughly mixed with seed, at a temperature of 55 DEG -75 DEG e.g for up to 2.5 minutes is then deposited onto a surface where it is allowed to crystallize under quiescent conditions at a temperature of about 50 DEG -70 DEG , until a solid cake is formed and is the comminuted to provide a free-flowing granular product which can be further dried. The process provides a particulate product in the form of crystals in a glossy matrix, in which 95% of the crystals have a particle size of less than 20 microns, the overall degree of crystallinity is greater than 70%, the bulk density is less than 0.65 and which is completely free of organic solvent residues. Other food ingredients may be added simultaneously with the seed.
Patent ES-8802054-A1 (ES)
Title: Griseolic acid derivatives, their preparation and their use.
IPC: C07D233/54
Filed: 1986-04-19
Abstract: New griseolic acid derivatives have various groups attached to the sugar part in place of the adenine group of griseolic acid itself. These groups are all purine derivatives or ring-opened purine analogs. The compounds are useful as inhibitors of phosphodiesterases. They may be prepared by replacing the adenine moiety of griseolic acid and/or dihydrodesoxygriseolic acid and/or by replacing other substituent groups.
Patent ES-8705946-A1 (ES)
Title: Well logging sonde.
IPC: G01V5/12
Filed: 1986-05-27
Abstract: A well logging sonde is disclosed which includes a collimating window design for the accurate detection of gamma rays of low and high energy which are back-scattered from a region near a source of gamma rays emitted into the formation. The sonde includes a tungsten support inner tube or shell surrounded by a length of "U" shaped steel. A conduit is formed in the wall of the shell at an angle with respect to its axis and is oriented symmetrically toward the opening of the "U" shaped steel support member. A closing member of a thin layer of titanium is welded to the open ends of the "U" shaped steel member. An arcuate tungsten pad is secured about the titanium closing member and partially about the exterior of the open ends of the "U" shaped steel support member. A conduit in the pad is aligned with the conduit of the inner shell to form a collimating window. A gamma ray detector of a length shorter than the "U" shaped steel section is mounted within the inner tube in the path of the collimating window.
Patent ES-8800954-A1 (ES)
Title: Microbicidal composition.
IPC: C07F9/38
Filed: 1986-06-10
Abstract: 1. Claims for the contracting States : BE CH DE FR GB IT LI LU NL SE A microbicidal agent containing as at least one active ingredient a compound of the formula I see diagramm : EP0207890,P22,F1 in which R is C1 -C4 alkyl or OH, R1 is OH X is hydrogen, halogen, C1 -C4 alkyl, C1 -C4 alkoxy, Si(CH3 )3 , -CN, -COOCH3 or -CH2 -CH(NH2 )-P(O)(R)(R1 ) and Y is hydrogen, halogen, halomethoxy, haloethoxy or halomethyl, with the inclusion of the corresponding salts together with a suitable carrier and/or wetting agent, a wetting agent always being present, if the active ingredient of the formula I simultaneously has the meanings R=R1 =OH and X=Y= hydrogen. 1. Claims for the Contracting State : AT a microbicidal agent containing as at least one active ingredient a compound of the formula I see diagramm : EP0207890,P23,F2 in which R is C1 -C4 alkyl or OH, R1 is OH X is hydrogen, halogen, C1 -C4 alkyl, C1 -C4 alkoxy, Si(CH3 )3 , -CN, -COOCH3 or -CH2 -CH(NH2 )-P(O)(R)(R1 ) and Y is hydrogen, halogen, halomethoxy, haloethoxy or halomethyl, with the inclusion of the corresponding salts together with a suitable carrier and/or wetting agent, a wetting agent always being present, if the active ingredient of the formula I simultaneously has the meanings R=R1 =OH and X=Y= hydrogen.
Patent IE-902089-A1 (IE)
Title: "A relay base for a radiotelephone communication system"
Inventor: ALARD MICHEL
IPC: H04B7/26
Filed: 1990-06-11
Abstract: The transmission base according to the invention comprises a receiver antenna (1) connected to an element (2) for coupling in reception associated with receiver elements (3) interfacing with digital processing units (4). The digital processing units (4) are connected to emitter elements (8) by way of interface lines (7) each associated with one of the digital processing units (4) and with the set of emitter elements (8), by parallel connections, each emitter element (8) comprising a switching element (9) controlling the placing in communication of the associated emitter element with one of the interface lines (7). 
<IMAGE>
Patent IE-912275-A1 (IE)
Title: Papermaking belt and method of making the same using different light transmission techniques
Inventor: TROKHAN PAUL DENNIS
IPC: B29D29/00
Filed: 1991-06-28
Abstract: A backside textured papermaking belt is disclosed which is comprised of a framework and a reinforcing structure. The framework has a first surface which defines the paper-contacting side of the belt, a second surface opposite the first surface, and conduits which extend between first and second surfaces of the belt. The first surface of the framework has a paper side network formed therein which defines the conduits. The second surface of the framework has a backside network with passageways that provide surface texture irregularities in the backside network. The papermaking belt is made by applying a coating of photosensitive resinous material to a reinforcing structure which has opaque portions, and then exposing the photosensitive resinous material to light of an activating wavelength through a mask which has transparent and opaque regions and also through the reinforcing structure. A process for making paper products is also disclosed which involves applying a fluid pressure differential from a vacuum source through the belt to a partially-formed embryonic web of papermaking fibers. The fibers in the embryonic web are deflected into the conduits of the papermaking belt by the vacuum pressure while the papermaking belt and the embryonic web travel over the vacuum source. Following the deflection, the paper web is impressed with the paper side network of the belt, and dried to form the final product.
Patent IE-912724-A1 (IE)
Title: Reduction or prevention of sensitization to drugs
IPC: A61K33/02
Filed: 1991-08-01
Abstract: The present invention is directed to a method of reducing or preventing skin sensitization by inhibiting the immunological processing of a sensitizing drug as an antigen. The drug is sensitizing to humans, i.e., the drug is susceptible to inducing skin or mucosa sensitization in a human when the drug is transdermally administered to the human at a therapeutically effective rate. Skin sensitization reduction or prevention is induced by coadministering to the skin or mucosa of the human: (a) a therapeutically effective amount of a sensitizing drug, at a therapeutically effective rate over a predetermined period of time; and (b) an antigen processing-inhibiting agent in an amount effective to inhibit the antigen processing of the drug. The system of the invention comprises a matrix adapted to be placed in sensitizing drug and antigen processing-inhibiting agent transmitting relation to the selected skin or mucosa site. The matrix contains sufficient amounts of the drug and the agent to continuously coadminister to the skin or mucosa site the drug, at a therapeutically effective rate and over a predetermined delivery period, and the antigen processing-inhibiting agent, at a rate and for a period of time sufficient to inhibit the processing of the drug as an antigen.